Review Article

|

2020, 13(10): 2595–2616

|

https://doi.org/10.1007/s12274-020-2904-8

Nanotechnologies for enhancing cancer immunotherapy

Jingxian Yang, Chunhui Wang, Shuo Shi (*), and Chunyan Dong (*)

View Author's information

Breast cancer center, Shanghai East Hospital, School of Medicine, Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, Shanghai 200120, China

Keywords: cancer immunotherapy, nanoplatform-based technology, combination therapy, synergistic effect
Full article PDF
Cite this article(Endnote)
Share this article
Metric

views: 203

Citations: 0

  • Abstract
  • References
Immunotherapy, a burgeoning field differs from traditional cancer treatments, is revolutionizing oncologic therapeutics. It aims to stimulate the innate and adaptive immune system of a patient to fight against tumor cells. However, low response rate and immune-related adverse effects (irAEs) remain problems during its management. A novel technology using nanomaterials may bring a solution. Various nanoparticles have been investigated as delivery systems to augment cancer therapeutic efficacy in the lab and clinic. In this review, we briefly summarize the connotation of immunotherapy, the application of nanotechnology in cancer, especially focusing on the synergistic effect of nanoplatform-based technology combined with cancer immunotherapy, hoping to make readers a deep insight into this interdisciplinary field.
Related Article
Cite this article

Nanotechnologies for enhancing cancer immunotherapy. Nano Res. 2020, 13(10): 2595–2616 https://doi.org/10.1007/s12274-020-2904-8

Download citation